Content about Levemir

May 22, 2012
Novo Nordisk's Levemir approved for children ages 2 to 5 years

The Food and Drug Administration has approved a treatment for Type 1 diabetes in children ages 2 to 5 years.

April 9, 2012
FDA approves labeling change for Novo Nordisk diabetes drug

The Food and Drug Administration has approved a change to the label of a Novo Nordisk drug stating that it offers superior blood-sugar control to a competing drug made by Merck, based on results of two clinical studies, Novo Nordisk said Monday.

April 2, 2012
FDA OKs Levemir for pregnant women

A diabetes treatment made by Novo Nordisk is safe for pregnant women, according to a recent decision by the Food and Drug Administration.

June 27, 2011
Novo Nordisk's Victoza helps patients achieve blood-sugar control when switching from exenatide or sitagliptin

Novo Nordisk unveiled data from two extension studies at the 71st annual Scientific Sessions of the American Diabetes Association in San Diego that show its diabetes drug, when combined with other medications, may help patients achieve blood-sugar control.

March 24, 2011
Novo Nordisk says Levemir is effective in treating young Type 1 diabetes patients

Novo Nordisk said new data showed that its basal insulin analog is just as effective as human basal insulin in Type 1 diabetes patients ages 2 to 5 years.

© 2013 Drug Store News. All Rights Reserved.